Suppr超能文献

去唾液酸糖蛋白受体调节以唾液酸α2,6-半乳糖结尾的血浆糖蛋白水平。

The asialoglycoprotein receptor regulates levels of plasma glycoproteins terminating with sialic acid alpha2,6-galactose.

作者信息

Steirer Lindsay M, Park Eric I, Townsend R Reid, Baenziger Jacques U

机构信息

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

出版信息

J Biol Chem. 2009 Feb 6;284(6):3777-83. doi: 10.1074/jbc.M808689200. Epub 2008 Dec 15.

Abstract

The asialoglycoprotein receptor (ASGP-R) is an abundant, carbohydrate-specific, endocytic receptor expressed by parenchymal cells of the liver. We recently demonstrated that the ASGP-R mediates the clearance of glycoproteins bearing Siaalpha2,6GalNAc as well as those bearing terminal Gal or GalNAc. We now report that glycoproteins such as haptoglobin, serum amyloid protein (SAP), and carboxylesterase that bear oligosaccharides with terminal Siaalpha2,6Gal are elevated in the plasma of ASGP-R-deficient mice. Because of their abundance in plasma, glycoproteins bearing terminal Siaalpha2,6Gal will saturate the ASGP-R and compete with each other on the basis of their relative affinities for the ASGP-R and their relative abundance. We propose that the ASGP-R mediates the clearance of glycoproteins that bear oligosaccharides terminating with Siaalpha2,6Gal and thereby helps maintain the relative concentrations of these glycoproteins in the blood.

摘要

去唾液酸糖蛋白受体(ASGP-R)是一种丰富的、碳水化合物特异性的内吞受体,由肝脏实质细胞表达。我们最近证明,ASGP-R介导带有Siaα2,6GalNAc的糖蛋白以及带有末端Gal或GalNAc的糖蛋白的清除。我们现在报告,在ASGP-R缺陷小鼠的血浆中,带有末端Siaα2,6Gal的寡糖的触珠蛋白、血清淀粉样蛋白(SAP)和羧酸酯酶等糖蛋白水平升高。由于它们在血浆中的丰度,带有末端Siaα2,6Gal的糖蛋白将使ASGP-R饱和,并根据它们对ASGP-R的相对亲和力和相对丰度相互竞争。我们提出,ASGP-R介导带有以Siaα2,6Gal结尾的寡糖的糖蛋白的清除,从而有助于维持这些糖蛋白在血液中的相对浓度。

相似文献

1
The asialoglycoprotein receptor regulates levels of plasma glycoproteins terminating with sialic acid alpha2,6-galactose.
J Biol Chem. 2009 Feb 6;284(6):3777-83. doi: 10.1074/jbc.M808689200. Epub 2008 Dec 15.
2
The asialoglycoprotein receptor clears glycoconjugates terminating with sialic acid alpha 2,6GalNAc.
Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17125-9. doi: 10.1073/pnas.0508537102. Epub 2005 Nov 14.
3
Rapid clearance of sialylated glycoproteins by the asialoglycoprotein receptor.
J Biol Chem. 2003 Feb 14;278(7):4597-602. doi: 10.1074/jbc.M210612200. Epub 2002 Dec 2.
4
Closely related mammals have distinct asialoglycoprotein receptor carbohydrate specificities.
J Biol Chem. 2004 Sep 24;279(39):40954-9. doi: 10.1074/jbc.M406647200. Epub 2004 Jul 15.
7
alpha3-galactosylated glycoproteins can bind to the hepatic asialoglycoprotein receptor.
Eur J Biochem. 2000 Nov;267(21):6501-8. doi: 10.1046/j.1432-1327.2000.01747.x.
8
Functional Consequences of Mannose and Asialoglycoprotein Receptor Ablation.
J Biol Chem. 2016 Sep 2;291(36):18700-17. doi: 10.1074/jbc.M116.738948. Epub 2016 Jul 12.
9
NMR study of ligand release from asialoglycoprotein receptor under solution conditions in early endosomes.
FEBS J. 2012 Aug;279(15):2645-56. doi: 10.1111/j.1742-4658.2012.08643.x. Epub 2012 Jun 14.
10
Evidence for an asialoglycoprotein receptor on nonparenchymal cells for O-linked glycoproteins.
J Pharmacol Exp Ther. 2008 Nov;327(2):308-15. doi: 10.1124/jpet.108.142232. Epub 2008 Aug 26.

引用本文的文献

2
Compositional and topological determinants of a physiological Ashwell-Morell receptor ligand.
Proc Natl Acad Sci U S A. 2025 Apr 15;122(15):e2427129122. doi: 10.1073/pnas.2427129122. Epub 2025 Apr 10.
3
Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines.
Signal Transduct Target Ther. 2025 Mar 10;10(1):73. doi: 10.1038/s41392-024-02112-8.
4
Integrated SegFlow, µSIA, and UPLC for Online Sialic Acid Quantitation of Glycoproteins Directly from Bioreactors.
Eng Life Sci. 2025 Jan 23;25(1):e202400031. doi: 10.1002/elsc.202400031. eCollection 2025 Jan.
5
PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies.
Molecules. 2023 May 10;28(10):4014. doi: 10.3390/molecules28104014.
7
Human FSH Glycoform α-Subunit Asparagine Glycans: Major Glycan Structural Consistency, Minor Glycan Variation in Abundance.
Front Endocrinol (Lausanne). 2022 Oct 18;13:767661. doi: 10.3389/fendo.2022.767661. eCollection 2022.
9
Therapeutic RNA-silencing oligonucleotides in metabolic diseases.
Nat Rev Drug Discov. 2022 Jun;21(6):417-439. doi: 10.1038/s41573-022-00407-5. Epub 2022 Feb 24.
10
New Opportunities in Glycan Engineering for Therapeutic Proteins.
Antibodies (Basel). 2022 Jan 10;11(1):5. doi: 10.3390/antib11010005.

本文引用的文献

1
The Ashwell receptor mitigates the lethal coagulopathy of sepsis.
Nat Med. 2008 Jun;14(6):648-55. doi: 10.1038/nm1760. Epub 2008 May 18.
3
The asialoglycoprotein receptor clears glycoconjugates terminating with sialic acid alpha 2,6GalNAc.
Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17125-9. doi: 10.1073/pnas.0508537102. Epub 2005 Nov 14.
4
A proteomic approach for the discovery of protease substrates.
Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11785-90. doi: 10.1073/pnas.0402353101. Epub 2004 Jul 27.
5
Rapid clearance of sialylated glycoproteins by the asialoglycoprotein receptor.
J Biol Chem. 2003 Feb 14;278(7):4597-602. doi: 10.1074/jbc.M210612200. Epub 2002 Dec 2.
10
The hepatic perisinusoidal stellate cell.
Histol Histopathol. 1997 Oct;12(4):1069-80.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验